Clinical trial
Early Predictors for the Short Term Native Liver Survival in Patients With Biliary Atresia After Kasai Procedure
NCT05909033 is registered in ClinicalTrials.gov with Weibing Tang as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Early Predictors for the Short Term Native Liver Survival in Patients With Biliary Atresia After Kasai Procedure
- Lead sponsor
- Weibing Tang
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- May 20, 2017
- Completion date
- July 1, 2023
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.